The 11 linked references in paper A. Kotov S., Yu. Tokareva V., V. Lutsik N., M. Panteleeva V., A. Shatalin V., E. Mukhina V., M. Bunak S., O. Andryukhina M., А. Котов С., Ю. Токарева В., В. Луцик Н., М. Пантелеева В., А. Шаталин В., Е. Мухина В., М. Бунак С., О. Андрюхина М. (2018) “Расстройство из спектра оптиконевромиелита в детском возрасте (клинический случай) // Neuromyelitis optica spectrum disorder in childhood (a case report)” / spz:neicon:rjdn:y:2017:i:4:p:56-62

  1. Abboud H., Petrak A., Mealy M. et al. Treatment of acute relapses in neuromyelitis optica: steroids alone versus steroids plus plasma exchange. Mult Scler 2016;22(2):185–92. DOI: 10.1177/1352458515581438.
  2. Bizzoco E., Lolli F., Repice A.M. et al. Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution. J Neurol 2009;256(11):1891–8. DOI: 10.1007/s00415-009-5171-x.
  3. Coutinho A.E., Chapman K.E. The antiinflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Mol Cell Endocrinol 2011;335(1):2–13. DOI: 10.1016/j.mce.2010.04.005.
  4. Jacob A., Matiello M., Weinshenker B.G. et al. Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients. Arch Neurol 2009;66(9):1128–33. DOI: 10.1001/archneurol.2009.175.
  5. Jiao Y., Fryer J.P., Lennon V.A. et al. Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica. Neurology 2013;81(14):1197–204. DOI: 10.1212/WNL.0b013e3182a6cb5c.
  6. Matiello M., Jacob A., Wingerchuk D.M., Weinshenker B.G. Neuromyelitis optica. Curr Opin Neurol 2007;20(3):255–60. DOI: 10.1097/WCO.0b013e32814f1c6b.
  7. Oh J., Levy M. Neuromyelitis optica: an antibody-mediated disorder of the central nervous system. Neurol Res Int 2012;2012:460825. DOI: 10.1155/2012/460825.
  8. Pandit L. Neuromyelitis optica spectrum disorders: an update. Ann Indian Acad Neurol 2015;18(suppl 1):S11–5. DOI: 10.4103/0972-2327.164816.
  9. Sherman E., Han M. Acute and chronic management of neuromyelitis optica spectrum disorder. Curr Treat Options Neurol 2015;17(11):48. DOI: 10.1007/s11940015-0378-x.
  10. Wingerchuk D.M., Banwell B., Bennett J.L. et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 2015;85(2):177–89. DOI: 10.1212/ WNL.0000000000001729.
  11. Wingerchuk D.M. Neuromyelitis optica: effect of gender. J Neurol Sci 2009;286(1–2): 18–23. DOI: 10.1016/j.jns.2009.08.045.